USA Susan L. Lang outlines how pharma companies can navigate drug formulary exclusions, numbers of which have been rising in recent years, and ensure that newly FDA approved medicines can make it to consumers. The pipeline for new therapies at the Food and Drug Administration mostly consists of novel brand…
See our Cookie Privacy Policy Here